HUTCHMED (China) Limited (HMDCF)
Develops cancer and immunological disease drugs for patients worldwide
$2.90+0.34%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-32.6%
The outlook
HMDCF is trading near the lower half of its 52-week range, with a mixed technical picture relative to its moving averages. The stock carries a low trailing P/E of 5.5, and analyst coverage appears thin based on available data. Overall sentiment sits neutral, reflecting no clear directional lean.
What’s behind the score
Price trendMixed vs its moving averages
52-week range45% of the way from its 52-week low to high
Market cap
$2.49B
52-wk high
$3.82
52-wk low
$2.16
50-day avg
$2.17
200-day avg
$2.94
Trailing P/E
5.5